HIV-1 Drug Resistance mutations against nucleotide reverse transcriptase inhibitors (NRTI), non-nucleotide reverse transcriptase inhibitors (NNRTI) and protease inhibitors (PI) identified by the ATCC assay versus the ViroSeq assay for those individual patients harbouring drug resistance mutations.
- Audu Rosemary (5464970)
- Onwuamah Chika (5464961)
- Okpokwu Jonathan (5464964)
- Imade Godwin (5465006)
- Odaibo Georgina (5464997)
- Okwuraiwe Azuka (5465009)
- Musa Zaidat (5465015)
- Chebu Philippe (5464991)
- Ezechi Oliver (5464976)
- Agbaji Oche (5464988)
- Olaleye David (5464979)
- Samuel Jay (5464967)
- Dalhatu Ibrahim (5465012)
- Ahmed Mukhtar (5464982)
- DeVos Joshua (5464994)
- Yang Chunfu (5464985)
- Raizes Elliot (5464973)
- Chaplin Beth (5465003)
- Kanki Phyllis (5465000)
- Idigbe Emmanuel (5465018)
Publication date
June 2018
DOIAbstract
<p>HIV-1 Drug Resistance mutations against nucleotide reverse transcriptase inhibitors (NRTI), non-nucleotide reverse transcriptase inhibitors (NNRTI) and protease inhibitors (PI) identified by the ATCC assay versus the ViroSeq assay for those individual patients harbouring drug resistance mutations.</p
Add to ORKG